Evidence map›Paper›PMID 32028323›Full record

ArticleEpidemiology (Cambridge, Mass.)2020

Validation of Questionnaire-based Case Definitions for Chronic Obstructive Pulmonary Disease.

Lydia Feinstein, Jesse Wilkerson, Paivi M Salo, Nathaniel MacNell, Matthew F Bridge, Michael B Fessler, Peter S Thorne, Angelico Mendy, Richard D Cohn, Matthew D Curry and 1 more

Open access · greenAbstract read
In one paragraph

Article in Epidemiology (Cambridge, Mass.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Lydia FeinsteinFrom the Social & Scientific Systems, Durham, NC.
Jesse WilkersonFrom the Social & Scientific Systems, Durham, NC.
Paivi M SaloDivision of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC.
Nathaniel MacNellFrom the Social & Scientific Systems, Durham, NC.
Matthew F BridgeFrom the Social & Scientific Systems, Durham, NC.
Michael B FesslerDivision of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC.
Peter S ThorneDepartment of Occupational and Environmental Health, University of Iowa, Iowa City, Iowa.
Angelico MendyDivision of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC.
Richard D CohnFrom the Social & Scientific Systems, Durham, NC.
Matthew D CurryFrom the Social & Scientific Systems, Durham, NC.
Darryl C ZeldinDivision of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC.
Social and Scientific Systems (United States) · USThe Centers · USUniversity of Iowa · USNational Institute of Environmental Health Sciences · USUniversity of North Carolina at Chapel Hill · US

Funding

Cell Signaling of Host DefenseZIAES102005 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FESSLER, MICHAEL B · 2009 to 2025
$41.7M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Indoor Allergens And AsthmaZIAES025041 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ZELDIN, DARRYL C · 2009 to 2025
$8.5M
INDOOR ALLERGENS AND ASTHMAZ01ES025041 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ZELDIN, DARRYL C · 1998 to 2008
$1.9M
Intramural NIH HHS Z01 ES025041NIAID NIH HHS HHSN272201600002INIEHS NIH HHS HHSN273201600002CNIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

backgroundVarious questionnaire-based definitions of chronic obstructive pulmonary disease (COPD) have been applied using the US representative National Health and Nutrition Examination Survey (NHANES), but few have been validated against objective lung function data. We validated two prior definitions that incorporated self-reported physician diagnosis, respiratory symptoms, and/or smoking. We also validated a new definition that we developed empirically using gradient boosting, an ensemble machine learning method.

methodsData came from 7,996 individuals 40-79 years who participated in NHANES 2007-2012 and underwent spirometry. We considered participants "true" COPD cases if their ratio of postbronchodilator forced expiratory volume in 1 second to forced vital capacity was below 0.7 or the lower limit of normal. We stratified all analyses by smoking history. We developed a gradient boosting model for smokers only; predictors assessed (25 total) included sociodemographics, inhalant exposures, clinical variables, and respiratory symptoms.

resultsThe spirometry-based COPD prevalence was 26% for smokers and 8% for never smokers. Among smokers, using questionnaire-based definitions resulted in a COPD prevalence ranging from 11% to 16%, sensitivity ranging from 18% to 35%, and specificity ranging from 88% to 92%. The new definition classified participants based on age, bronchodilator use, body mass index (BMI), smoking pack-years, and occupational organic dust exposure, and resulted in the highest sensitivity (35%) and specificity (92%) among smokers. Among never smokers, the COPD prevalence ranged from 4% to 5%, and we attained good specificity (96%) at the expense of sensitivity (9-10%).

conclusionOur results can be used to parametrize misclassification assumptions for quantitative bias analysis when pulmonary function data are unavailable.

Indexed as

Nutrition SurveysPulmonary Disease, Chronic ObstructiveAdultAgedFemaleForced Expiratory VolumeHumansMaleMiddle AgedPrevalenceReproducibility of ResultsSpirometryVital Capacity

Identifiers

PMID32028323
PMCPMC7138734
OpenAlexW3004808374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.